S-1 · resale registration
Issued 2026
Proposed maximum
Shares registered
- Filed
- Effective
MEDS$1.69-7.65%
DataMeds AI, Inc.
Sector: Wholesale-Drugs, Proprietaries & Druggists' SundriesIndustry: Medical - DistributionCountry: USExchange: Nasdaq
Mkt Cap:$7.63M
Float & O/S:
Inst Own:
DilutionScan read 31 of DataMeds AI, Inc.'s SEC filings and found 7 warrant series, 6 convertibles, 1 equity line, 1 shelf registration, 4 S-1 registrations and 18 completed offerings on file for MEDS. The latest dilution event on file is an offering on Oct 13, 2026. Analysis updated Oct 26, 2026.
Signal8 Summary
MEDS
Near-insolvent micro-cap burning cash
Snapshot
DataMEDS AI is a tiny, cash-strapped micro-cap health IT and pharmacy company. Revenue grew 28.7% to $23.3M in FY 2025, but gross margin turned negative (-41.3%), meaning each sale loses money before other costs.
What's Happening Right Now
- : On Sep 8, 2026, DataMEDS and Tollo Health partnered with the NFL Alumni Association to roll out a telehealth and pharmacy-access campaign for rural communities through the Health Lives Here app.
- : On Aug 17, 2026, DataMEDS reported Q2 2026 revenue of $1.779M (up 14% sequentially), disclosed a $6.5M funding round, a completed 1-for-50 reverse split to address delisting risk, and a meme coin token distribution to shareholders.
- : On Aug 12, 2026, DataMEDS said its Corexa Pharmacy division stabilized at over $600,000 in July 2026 revenue and completed integration of its online store, adding GLP-1 drug offerings.
- : On Jul 29, 2026, DataMEDS expanded its blockchain data-licensing agreement with Datavault AI, extending its PharmacyChain technology beyond pharmaceutical distribution into broader healthcare and wellness data monetization.
- : On Jun 26, 2026, the company was renamed DataMeds AI, Inc. from Wellgistics Health, reflecting a pivot toward a vertically integrated data, pharmacy, and telemedicine model.
Raise routes on file: effective shelf + pending S-1 + effective S-1 · latest dilution event 21 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Oct 13, 2026 · Offering
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Filed
S-1 · primary offering
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
S-1 · resale registration
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
S-1 · primary offering
Issued 2024
Proposed maximum
Shares registered
- Filed
- Effective
Warrant
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2026
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2026
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
May 2026 PIPE Warrants
Issued 2026
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Convertible
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Convertible
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
January 2026 Secured Convertible Promissory Notes (Original Notes)
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
April 1, 2026 Convertible Promissory Note (Original Note)
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
May 20, 2026 Convertible Promissory Note (Original Note)
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Series A Convertible Preferred Stock
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Equity line
Issued 2025
Commitment
Sold to date
Remaining
- Agreement date
- Term ends
- Discount
S-3 shelf registration
Issued 2026
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
Public offering
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Offering
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Offering
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Offering
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
PIPE
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
PIPE
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your MEDS trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
